Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2024

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

The table below summarizes the significant revenue and expense categories regularly reviewed by the CODM for the years ended December 31, 2024, and 2023:

	For the Years Ended December 31,
	2024		2023
Revenues
Product sales, net	$	680,501	$	462,175
Grant revenue	351		2,195
Total revenues, net	680,852		464,370
Expenses
Cost of product sales	56,963		33,745
SG&A: Selling expenses	384,744		324,499
SG&A: General and administrative expenses	119,745		85,365
R&D: Lumateperone project costs	138,561		111,881
R&D: Non-lumateperone project costs	60,200		37,638
R&D: Other and overhead	37,360		30,623
Other segments items(1)	(42,045)		(19,707)
Net loss	$	(74,676)	$	(139,674)

(1) Other segment items included in expenses includes interest income and income tax (benefit) loss.